Literature DB >> 12743425

Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer.

Masahide Ikeguchi1, Ken-ichi Yamaguchi, Nobuaki Kaibara.   

Abstract

OBJECTIVE: The correlation between survivin gene expression and the occurrence of spontaneous apoptosis, proliferative activity of cancer cells, tumor angiogenesis, and abnormal p53 nuclear accumulation was evaluated in esophageal cancer.
METHODS: A total of 57 patients, on whom surgical esophageal resection had been performed between 1993 and 2000, were enrolled in this study. Total RNA was extracted from tumors and noncancerous epithelia. Expression levels of survivin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) messenger RNA (mRNA) were analyzed quantitatively by real-time reverse transcriptase polymerase chain reaction (quantitative PCR). The proliferative activity of cancer cells, apoptotic cancer cells, microvessel density, and abnormal p53 nuclear accumulation were analyzed in these tumors.
RESULTS: The expression level of tumor survivin mRNA described as survivin/GAPDH (s/G) ratio was higher than that of noncancerous tissue (p = 0.0003), but did not correlate with lymph node metastasis, with the depth of tumor invasion, with the occurrence of apoptosis or with tumor angiogenesis. However, the tumor s/G ratio positively correlated with the proliferative activity and p53 nuclear accumulation in cancer cells. The 5-year survival rate of 53 patients was 37% (we excluded 4 patients who died from operative complications from this survival study). The 5-year survival rate of 27 patients with a high tumor s/G ratio (28.6%) was lower than that of 26 patients with a low tumor s/G ratio (46.2%, p = 0.041). High tumor s/G ratio was detected as an important prognostic factor independent of tumor stage.
CONCLUSION: Detection of survivin mRNA by quantitative PCR provided us with important prognostic and biological information regarding esophageal cancer patients. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743425     DOI: 10.1159/000070659

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  9 in total

1.  The RNA-binding protein CUG-BP1 increases survivin expression in oesophageal cancer cells through enhanced mRNA stability.

Authors:  Elizabeth T Chang; James M Donahue; Lan Xiao; Yuhong Cui; Jaladanki N Rao; Douglas J Turner; William S Twaddell; Jian-Ying Wang; Richard J Battafarano
Journal:  Biochem J       Date:  2012-08-15       Impact factor: 3.857

Review 2.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

3.  Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma.

Authors:  Xiaoya Yang; Gang Xiong; Xuedan Chen; Xueqing Xu; Kai Wang; Yong Fu; Kang Yang; Yun Bai
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-08       Impact factor: 4.553

Review 4.  Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.

Authors:  Yan Liu; Lin Li; Haiyan Qi; Yan Gao; Sha Liu; Chongan Xu
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

5.  Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system.

Authors:  Mariam A Stoff-Khalili; Alexander Stoff; Angel A Rivera; Nilam S Banerjee; Maaike Everts; Scott Young; Gene P Siegal; Dirk F Richter; Minghui Wang; Peter Dall; J Michael Mathis; Zeng B Zhu; David T Curiel
Journal:  Breast Cancer Res       Date:  2005-11-16       Impact factor: 6.466

Review 6.  Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.

Authors:  Meilan Chen; Jizheng Huang; Zhenli Zhu; Jun Zhang; Ke Li
Journal:  BMC Cancer       Date:  2013-11-11       Impact factor: 4.430

7.  Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo.

Authors:  Lei Wang; Jianfang Feng; Xiaonan Chen; Wei Guo; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Shijie Zhang; Guoqiang Zhao
Journal:  Cancer Cell Int       Date:  2014-07-18       Impact factor: 5.722

8.  Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer.

Authors:  Jaewon Choi; Yu Kyeong Hwang; Young Jin Choi; Ki Eun Yoo; Jeong Han Kim; Seok Jin Nam; Jung Hyun Yang; Sang Jin Lee; Keon Hee Yoo; Ki Woong Sung; Hong Hoe Koo; Young Hyuck Im
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

9.  Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma.

Authors:  Haiying Peng; Shaobo Yao; Qingyu Dong; Yanxia Zhang; Weihong Gong; Zhongyao Jia; Li Yan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.